Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04982315 · ClinicalTrials.gov registry record · NA

Acupuncture for Chronic Low Back Pain in Older Adults

A NA study, sponsored by Kaiser Permanente.

Completed
Registry status
NA
Development phase
807
Enrollment target

NCT04982315: Completed NA study, sponsored by Kaiser Permanente.

NCT04982315 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 807 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (43% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04982315, a NA study, has completed, sponsored by Kaiser Permanente.

COMPLETED
Registry status
NA
Development phase
807 participants
Enrollment target

Study Summary

The main goal of the BackInAction research study is to determine the effectiveness of a standard course of acupuncture (15 sessions of acupuncture over 3 months) and an enhanced course of acupuncture (an additional 6 sessions of acupuncture over months 4-6) in improving back-related disability in older adults (65+ years) with chronic low back pain compared to usual care alone. Key secondary aims are to determine the effectiveness of acupuncture in improving a composite score of pain intensity and pain interference.

Primary Outcome

Change in back-related disability is defined as score change in Roland Morris Disability Questionnaire (RMDQ), a 24-item questionnaire which asked whether 24 specific activities were limited due to back pain during the past week. The RMDQ is scored from 0 to 24, with higher scores indicating more disability. Greater change between baseline and 6-months would indicate greater improvement.

Interventions

  • PROCEDURE Standard Acupuncture
  • PROCEDURE Enhanced Acupuncture

Trial Details

FieldValue
Enrollment Target 807 participants
Start Date 2021-08-12
Est. Completion 2024-02-07
Phase NA
Kaiser Permanente

294 total trials

What the finished NCT04982315 record still lists

NCT04982315 is an interventional study that assigns participants to a tested intervention. The registered 807 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (43% lower).

The record links to 0 conditions, and to 2 interventions - of which Standard Acupuncture is the first listed.

NCT04982315 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04982315 about?

NCT04982315 is a clinical study titled "Acupuncture for Chronic Low Back Pain in Older Adults". The main goal of the BackInAction research study is to determine the effectiveness of a standard course of acupuncture (15 sessions of acupuncture over 3 months) and an enhanced course of acupuncture (an additional 6 sessions of acupuncture over months 4-6) in improving back-related disability in ol...

What is the current status of trial NCT04982315?

This trial is currently completed. It is a NA study. The enrollment target is 807 participants. The study started on 2021-08-12. Estimated completion is 2024-02-07.

What interventions are being tested in trial NCT04982315?

The interventions under investigation include: Standard Acupuncture (PROCEDURE), Enhanced Acupuncture (PROCEDURE).

Who is sponsoring clinical trial NCT04982315?

This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04982315's enrollment target sits among peer trials

807 134th of 2000 higher than 1,867 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06529094 · 808 participants · NA

    Implementing a Decision Support Tool to Prevent Community-Acquired Pressure Injury in Spinal Cord Injury (SCI) in the Spinal Cord Injury Clinic

  • NCT04613596 · 806 participants · Phase 2

    Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

  • NCT06065098 · 806 participants · NA

    Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health

  • NCT05519085 · 810 participants · Phase 3

    A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04982315, the US trial registry maintained by the National Library of Medicine. NCT04982315 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.